News Archives - Page 2 of 768

FridayMar 06, 2026 9:16 am

QualityStocksNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Announces Peer-Reviewed Publication Highlighting Pharmacokinetics of TONMYA(TM) Sublingual Tablets

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated commercial biotechnology company, announced the publication of a peer-reviewed paper detailing results from randomized open-label studies evaluating the pharmacokinetics of TNX-102 SL, the sublingual formulation of cyclobenzaprine HCl marketed as TONMYA(TM). Published in Clinical Pharmacology in Drug Development, the journal of the American College of Clinical Pharmacology, the study highlights how TONMYA’s proprietary basifying agent enables rapid transmucosal absorption that bypasses first-pass hepatic metabolism. The formulation, approved by the U.S. Food and Drug Administration on Aug. 15, 2025, for the treatment of fibromyalgia in adults, is designed to increase parent drug exposure during sleep while reducing exposure to…

FridayMar 06, 2026 9:00 am

Beeline Holdings Inc. (NASDAQ: BLNE) AI-Driven Mortgage Platform Prioritizes Speed, Easy Access for Personal Home Buyers and Investors

Beeline Holdings operates a fully digital mortgage and title platform built around AI and automation, with core tools such as AI chatbot Bob and workflow engine Hive designed to shorten mortgage closing timelines. The company targets both primary home buyers and real estate investors, with a focus on younger borrowers and equity-rich homeowners, emphasizing self-service access to rates, approvals, and documentation, available online at all times. Management has outlined plans to further scale transaction volume and software-based offerings in 2026. Beeline Holdings (NASDAQ: BLNE), a rapidly growing digital mortgage platform company redefining the path to homeownership, operates at the intersection…

ThursdayMar 05, 2026 11:15 am

MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) Begins Strategic Drilling at Bracken to Expand Basin-Scale Natural Hydrogen Potential

Disseminated on behalf of MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) and may include paid advertising. “We’re excited about the potential of this second play concept to deliver meaningful results and demonstrate basin-scale continuity for natural hydrogen in Saskatchewan,” said CEO. The Bracken well will test what MAX Power describes as a “stratigraphic play concept.” The strategic importance of the Bracken drilling program goes beyond geological exploration. MAX Power Mining (CSE: MAXX) (OTC: MAXXF) has launched an exciting new phase in its natural hydrogen exploration campaign with the commencement of drilling at its Bracken target. This significant milestone could…

ThursdayMar 05, 2026 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Advances Processing Strategy amid Rising Rare Earth Prices

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. The prices for the rare earths most critical to automotive and high-tech manufacturing have climbed 37 to 105% since the start of the year. “These price differentials . . . underscore the importance of the developing North American supply chain,” said Ucore CEO. Demonstration data supports deployment at Ucore’s planned Strategic Metals Complex, where the first commercial RapidSX unit is targeted for commissioning in 2026. Rare earth element prices have moved sharply higher in recent months, reflecting tightening global supply and sustained demand from…

ThursdayMar 05, 2026 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Leverages Platform Science for Broader Therapeutic Reach

Platform-based drug development has gained traction across the biotechnology industry because of its efficiency and risk management advantages. Soligenix’s development of synthetic hypericin illustrates this “one drug, multiple diseases” model in action. HyBryte is being developed to treat both cutaneous T-cell lymphoma (“CTCL”), a rare form of non-Hodgkin lymphoma that primarily affects the skin, and psoriasis. Modern biopharmaceutical innovation often revolves around a powerful idea: One scientific mechanism can unlock treatments for multiple diseases. Rather than building entirely new molecules for every indication, companies are developing platform technologies that allow a single therapeutic approach to be adapted across conditions. Soligenix…

ThursdayMar 05, 2026 9:00 am

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Secures $807,000 from Warrant Exercises to Advance Murdock Mountain Project

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. Nevada Organic Phosphate, targeting the growing need for phosphate fertilizer for the expanding organic foods market, has received proceeds from the exercise of 14.6 million warrants. The company’s cash on hand now totals approximately $1.25 million, and the capital will help support Phase II drilling at the Murdock Mountain Project in Nevada. The Murdock Mountain deposit may represent one of the only large-scale organic sedimentary phosphate resources in North America. Remaining warrants could generate roughly $2.46 million if exercised. Nevada Organic Phosphate (CSE:…

ThursdayMar 05, 2026 8:52 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the enrollment of the first patients in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection. The first patients were enrolled by Prof. Dr. Vladan Vukcevic at the University Clinical Center of Serbia in Belgrade, marking a key step toward generating the clinical data needed to expand the HeartBeam System’s indication beyond arrhythmia assessment to include heart attack detection. To view the full press release, visit https://ibn.fm/afbcv About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company…

ThursdayMar 05, 2026 8:52 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules March 12 Conference Call to Review Q4 and Full-Year 2025 Results

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights, will host a conference call at 4:30 p.m. Eastern time on March 12, 2026, to discuss its financial results for the fourth quarter and full year ended Dec. 31, 2025, and provide updates on key strategic growth initiatives, including the limited commercial launch and progress on its 12-lead ECG extended wear patch. A press release detailing the results will be issued prior to the call. To view the full press release, visit https://ibn.fm/x2atK About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming…

WednesdayMar 04, 2026 11:15 am

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Year-End Report Shows Alignment with Domestic Resource Priorities, Strong Strategic Positioning

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. Domestic critical minerals production has become a priority for US policymakers seeking to reduce supply-chain vulnerabilities. In its fiscal 2025 year-end update, Trilogy highlighted progress tied to broader federal support for domestic critical minerals initiatives. Beyond policy alignment, Trilogy’s year-end results provided updates on financial and strategic positioning. As governments worldwide focus on strengthening supply chains for strategic resources, domestic production of critical minerals has emerged as a central pillar of industrial policy. In the United States, concerns about reliance on foreign sources…

WednesdayMar 04, 2026 10:30 am

CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) to Execute Comprehensive Exploration Plan Focused on Promising Potential of Multiple Additional Silver-Bearing Veins

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX Gold & Silver Corp., an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, is on track to execute a plan this spring for a comprehensive geophysical program at its flagship plant The geophysical program will include 3-D DCIP and MT surveys to delineate known structures on the property This follows the announced plan to undertake a non-brokered private placement financing to raise CAN$2,000,000 from the sale of 8,000,000 units at CAN$0.25 a unit For investors, it’s important to remember…

Site Search

Company Search

Category: News